Forte Biosciences Ownership | Who Owns Forte Biosciences?

Forte Biosciences Ownership Summary

Forte Biosciences is owned by 41.38% institutional investors, 10.96% insiders, and 47.66% retail investors. Geode capital management is the largest institutional shareholder, holding 0.75% of FBRX shares. Alger LIfe Sciences Innovation Composite is the top mutual fund, with 3.12% of its assets in Forte Biosciences shares.

FBRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Forte Biosciences	41.38%	10.96%	47.66%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Geode capital management	346.29K	0.75%	$186.01K
Blackrock	174.86K	0.38%	$93.90K
Two sigma investments, lp	40.81K	0.09%	$21.92K
State street	37.56K	0.08%	$20.17K
Susquehanna group, llp	34.34K	0.07%	$18.44K
Ubs group	24.31K	0.05%	$13.05K
Goldman sachs group	20.78K	0.05%	$11.16K
Group one trading	14.02K	0.03%	$7.53K
Morgan stanley	3.80K	0.01%	$2.04K
Citadel advisors	3.10K	0.01%	$1.67K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Loring wolcott & coolidge fiduciary advisors llp/ma	-	-	-
Renaissance	-	-	-
Blackrock	174.86K	-	$93.90K
Two sigma advisers, lp	-	-	-
Tower research capital llc (trc)	-	-	-
Two sigma securities	-	-	-
Bvf inc/il	-	-	-
Susquehanna group, llp	34.34K	-	$18.44K
Advisor group	-	-	-
Geode capital management	346.29K	-	$186.01K

Top Buyers

Holder	Shares	% Assets	Change
Susquehanna group, llp	34.34K	-	34.34K
Ubs group	24.31K	-	24.28K
Geode capital management	346.29K	-	2.86K
Morgan stanley	3.80K	-	2.81K
Citadel advisors	3.10K	-	2.10K

Top Sellers

Holder	Shares	% Assets	Change
Tybourne capital management (hk)	-	-	-3.62M
Perceptive advisors	-	-	-3.27M
Bvf inc/il	-	-	-2.98M
Cable car capital	-	-	-2.03M
Fred alger management	-	-	-1.84M

New Positions

Holder	Shares	% Assets	Change	Value
Susquehanna group, llp	34.34K	-	34.34K	$18.44K

Sold Out

Holder	Change
Qube research	-3.00
Fmr	-128.00
Loring wolcott & coolidge fiduciary advisors llp/ma	-193.00
Wells fargo & company/mn	-253.00
Advisor group	-1.08K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	33	3.13%	19,068,395	0.10%	41	1.14%	10	42.86%	6	20.00%
Mar 31, 2024	32	-8.57%	19,048,537	0.98%	60	2.43%	7	-30.00%	5	-
Dec 31, 2023	35	9.38%	18,863,225	12.96%	49	0.79%	10	-28.57%	5	-28.57%
Sep 30, 2023	32	3.23%	16,699,693	381.91%	79	29.16%	14	27.27%	7	-12.50%
Jun 30, 2023	31	3.33%	3,465,339	-10.35%	16	4.87%	11	37.50%	8	-11.11%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Alger LIfe Sciences Innovation Composite	205.60K	3.12%	-1.53K
Alger Small Cap Focus Composite	159.55K	2.42%	-
Alger Small Cap Focus I	159.55K	2.42%	-
Alger Health Sciences A	134.57K	2.04%	-
Biotech Growth Ord	90.00K	1.41%	90.00K
Alger Dynamic Opportunities A	81.53K	1.24%	-55.80K
Alger Large Cap Growth I-2	71.79K	1.09%	30.15K
Alger Large Cap Growth Composite	71.79K	1.09%	30.15K
Alger Small Cap Growth B	70.05K	1.06%	-
Vanguard Institutional Extnd Mkt Idx Tr	46.54K	0.71%	39.75K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 21, 2024	Riley Antony A	CHIEF FINANCIAL OFFICER	Buy	$125.00K
Dec 18, 2023	Wagner Paul A.	See Remarks	Buy	$7.53K
Dec 13, 2023	Wagner Paul A.	See Remarks	Buy	$7.35K
Dec 14, 2023	Wagner Paul A.	See Remarks	Buy	$7.20K
Dec 11, 2023	Wagner Paul A.	See Remarks	Buy	$16.19K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	1	-
2024 Q3	-	-
2024 Q2	-	-

FBRX Ownership FAQ

Who Owns Forte Biosciences?

Forte Biosciences shareholders are primarily institutional investors at 41.38%, followed by 10.96% insiders and 47.66% retail investors. The average institutional ownership in Forte Biosciences's industry, Biotech Stocks , is 68.48%, which Forte Biosciences falls below.

Who owns the most shares of Forte Biosciences?

Forte Biosciences’s largest shareholders are Geode capital management (346.29K shares, 0.75%), Blackrock (174.86K shares, 0.38%), and Two sigma investments, lp (40.81K shares, 0.09%). Together, they hold 1.22% of Forte Biosciences’s total shares outstanding.

Does Blackrock own Forte Biosciences?

Yes, BlackRock owns 0.38% of Forte Biosciences, totaling 174.86K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 93.9K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Forte Biosciences’s biggest shareholder by percentage of total assets invested?

Loring wolcott & coolidge fiduciary advisors llp/ma is Forte Biosciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Forte Biosciences shares, valued at 0$.

Who is the top mutual fund holder of Forte Biosciences shares?

Alger LIfe Sciences Innovation Composite is the top mutual fund holder of Forte Biosciences shares, with 3.12% of its total shares outstanding invested in 205.6K Forte Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools